(Q36219670)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Emerging drugs for obesity: linking novel biological mechanisms to pharmaceutical pipelines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

William G. Haynes

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Marcelo L G Correia

series ordinal

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Emerging Drugs

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

643-660

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Associations of short-term weight changes and weight cycling with incidence of essential hypertension in the EPIC-Potsdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Surgery for severe obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Bariatric surgery worldwide 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Clinical pharmacotherapy for obesity: current drugs and those in advanced development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Cost-effectiveness of sibutramine in the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Leptin action in the forebrain regulates the hindbrain response to satiety signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

The arcuate nucleus as a primary site of satiety effect of leptin in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Identification of targets of leptin action in rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Leptin receptor signaling in POMC neurons is required for normal body weight homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Targeted disruption of the melanocortin-4 receptor results in obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Melanocortin receptors in leptin effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Effects of fasting, leptin, and insulin on AGRP and POMC peptide release in the hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Hypothalamic interactions between neuropeptide Y, agouti-related protein, cocaine- and amphetamine-regulated transcript and alpha-melanocyte-stimulating hormone in vitro in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Hypothalamic CART is a new anorectic peptide regulated by leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Increases in melanin-concentrating hormone and MCH receptor levels in the hypothalamus of dietary-obese rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Circulating melanin-concentrating hormone, agouti-related protein, and alpha-melanocyte-stimulating hormone levels in relation to body composition: alterations in response to food deprivation and recombinant human leptin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Melanin-concentrating hormone neuron system: the Wide Web that controls the feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Effects of selective CCK receptor agonists on food intake after central or peripheral administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Ghrelin induces adiposity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Leptin-like effects of MTII are augmented in MSG-obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Peptides that regulate food intake: antagonism of opioid receptors reduces body fat in obese rats by decreasing food intake and stimulating lipid utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Current and investigational antiobesity agents and obesity therapeutic treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Pharmacotherapy of obesity: lessons from clinical trials in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

Leptin and the central neural mechanisms of obesity hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728214.10.3.643

10.1517/14728214.10.3.643

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16083333%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference